Dalteparin Sodium

CHEBI:CHEBI_747136

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

pharm_class
Low Molecular Weight Heparin [EPC]
rxcui
2618842
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20251231
dosage_form
INJECTION
marketing_start_date
20221017
package_marketing_start_date
20221017
route
SUBCUTANEOUS
generic_name
Dalteparin Sodium
brand_name
Fragmin
brand_name_base
Fragmin
product_ndc
0069-0206
application_number
NDA020287
labeler_name
Pfizer Laboratories Div Pfizer Inc
manufacturer_name
Pfizer Laboratories Div Pfizer Inc
spl_id
b635de45-b77e-4c7b-9c46-32e631e552db
active_ingredient_name
DALTEPARIN SODIUM
active_ingredient_strength
7500 [iU]/.3mL
package_ndc
0069-0206-02
package_description
10 SYRINGE in 1 CARTON (0069-0206-02) / .3 mL in 1 SYRINGE (0069-0206-01)
unii
12M44VTJ7B
spl_set_id
23527b8b-9b28-4e6d-9751-33b143975ac7
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class